ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT)
CUSIP: 77313F106
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 109,265,652
- Total 13F shares
- 107,749,040
- Share change
- -1,886,654
- Total reported value
- $722,024,357
- Put/Call ratio
- 40%
- Price per share
- $6.67
- Number of holders
- 233
- Value change
- -$52,696,378
- Number of buys
- 155
- Number of sells
- 74
Quarterly Holders Quick Answers
What is CUSIP 77313F106?
CUSIP 77313F106 identifies RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 77313F106:
Top shareholders of RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
—
mixed-class rows
|
18,037,772
mixed-class rows
|
$222,347,299 | — | 31 Dec 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
13%
|
13,995,177
|
$175,919,375 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
6.5%
|
7,097,287
|
$89,212,901 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
6%
|
6,577,595
|
$82,680,369 | — | 31 Dec 2024 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
4.8%
|
5,198,900
|
$65,350,173 | — | 31 Dec 2024 | |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
|
Company |
4.3%
|
4,714,610
|
$59,262,648 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
mixed-class rows
|
4,460,428
mixed-class rows
|
$51,835,477 | — | 31 Dec 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.7%
|
4,004,039
|
$50,342,665 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.2%
|
3,458,079
|
$43,468,053 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.9%
|
3,148,520
|
$39,578,000 | — | 31 Dec 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
2,566,951
|
$32,266,574 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
1,752,975
|
$22,040,580 | — | 31 Dec 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.4%
|
1,569,823
|
$19,732,679 | — | 31 Dec 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.4%
|
1,479,025
|
$18,591,344 | — | 31 Dec 2024 | |
| Boxer Capital Management, LLC |
13F
|
Company |
1.3%
|
1,466,051
|
$18,428,261 | — | 31 Dec 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
1.2%
|
1,317,969
|
$16,566,870 | — | 31 Dec 2024 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
1.1%
|
1,200,000
|
$15,084,000 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
1,184,709
|
$14,891,795 | — | 31 Dec 2024 | |
| Novo Holdings A/S |
13F
|
Company |
1%
|
1,100,000
|
$13,827,000 | — | 31 Dec 2024 | |
| TORONTO DOMINION BANK |
13F
|
Company |
1%
|
1,100,000
|
$13,827,000 | — | 31 Dec 2024 | |
| Prosight Management, LP |
13F
|
Company |
1%
|
1,088,706
|
$13,685,034 | — | 31 Dec 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
0.96%
|
1,053,300
|
$13,239,981 | — | 31 Dec 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.93%
|
1,020,559
|
$12,828,427 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.73%
|
802,785
|
$10,091,012 | — | 31 Dec 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.72%
|
791,877
|
$9,953,897 | — | 31 Dec 2024 | |
| COMERICA BANK |
13F
|
Company |
0.71%
|
780,380
|
$9,809,377 | — | 31 Dec 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.71%
|
770,691
|
$9,687,586 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.7%
|
760,941
|
$9,564,672 | — | 31 Dec 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.69%
|
750,000
|
$9,427,500 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.61%
|
663,152
|
$8,335,821 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.6%
|
656,090
|
$8,247,051 | — | 31 Dec 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.6%
|
653,559
|
$8,215,237 | — | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.6%
|
652,421
|
$8,200,932 | — | 31 Dec 2024 | |
| Siren, L.L.C. |
13F
|
Individual |
0.55%
|
600,000
|
$7,542,000 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.52%
|
569,963
|
$7,164,435 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.47%
|
515,528
|
$6,480,187 | — | 31 Dec 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.42%
|
456,762
|
$5,741,499 | — | 31 Dec 2024 | |
| Voss Capital, LP |
13F
|
Company |
0.39%
|
421,700
|
$5,300,769 | — | 31 Dec 2024 | |
| Privium Fund Management B.V. |
13F
|
Company |
0.36%
|
397,650
|
$4,998,461 | — | 31 Dec 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.38%
|
413,550
|
$4,975,007 | — | 31 Dec 2024 | |
| M28 Capital Management LP |
13F
|
Company |
0.35%
|
385,680
|
$4,847,998 | — | 31 Dec 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.35%
|
378,584
|
$4,758,801 | — | 31 Dec 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.33%
|
357,840
|
$4,498,049 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.31%
|
336,909
|
$4,234,946 | — | 31 Dec 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.25%
|
271,792
|
$3,416,425 | — | 31 Dec 2024 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.25%
|
271,659
|
$3,414,754 | — | 31 Dec 2024 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.25%
|
270,983
|
$3,406,256 | — | 31 Dec 2024 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
0.22%
|
237,499
|
$2,985,362 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.21%
|
233,952
|
$2,940,779 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.21%
|
224,311
|
$2,819,589 | — | 31 Dec 2024 |
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) as of Q1 2025
As of 31 Mar 2025,
ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT) was held by
233 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
107,749,040 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., VANGUARD GROUP INC, MAVERICK CAPITAL LTD, WESTFIELD CAPITAL MANAGEMENT CO LP, STATE STREET CORP, SUVRETTA CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
234
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
222
Q1 2025 holders
233
Holder diff
11
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.